...
首页> 外文期刊>Clinical Biochemistry >A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR
【24h】

A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR

机译:稳定剂可防止血液样本在储存和运输过程中血浆中的细胞DNA污染无细胞DNA(如数字PCR所确定)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objectives: To study the ability of a stabilizing reagent to prevent cellular DNA contamination of cell-free DNA (cfDNA) in plasma during whole blood sample storage and shipping. Design and methods: Samples were drawn from healthy donors into K3EDTA and Cell-Free DNA BCTs (BCT) and stored at room temperature (RT). Aliquots were removed at specified time points and cfDNA was purified from the plasma. A Droplet Digital PCR (ddPCR) assay that amplifies a short β-actin gene fragment (136bp) was used to measure the total plasma cfDNA (pDNA) concentration while a longer β-actin fragment (420bp) was used to quantify genomic DNA (gDNA). In a follow-up experiment, blood samples drawn into the same types of tubes were shipped round trip by overnight air before cfDNA was isolated and analyzed. Results: Blood stored in K3EDTA tubes at RT showed increases in pDNA and gDNA concentrations over time. However, both pDNA and gDNA levels remained stable in BCT for at least seven days. On day 14, there was a 4.5-fold increase in pDNA in BCT as compared to 200-fold increase in K3EDTA tubes. Likewise, gDNA increased 2-fold on day 14 in BCT as opposed to a 456-fold increase in K3EDTA tubes. Similar results were observed after samples were shipped. Conclusions: Cell-Free DNA BCTs prevent gDNA contamination that may occur due to nucleated cell disruption during sample storage and shipping. This novel blood collection tube provides a method for obtaining stable cfDNA samples for rare target detection and accurate analysis while mitigating the threat of gDNA contamination.
机译:目的:研究稳定剂在全血样本存储和运输过程中防止血浆中无细胞DNA(cfDNA)的细胞DNA污染的能力。设计和方法:从健康供体中抽取样品到K3EDTA和无细胞DNA BCT(BCT)中,并在室温(RT)下保存。在指定的时间点取出等分试样,并从血浆中纯化cfDNA。使用Droplet Digital PCR(ddPCR)分析法扩增一个短的β-actin基因片段(136bp)以测量血浆总cfDNA(pDNA)浓度,而使用较长的β-actin片段(420bp)量化基因组DNA(gDNA) )。在后续实验中,在分离和分析cfDNA之前,通宵通宵运送进入相同类型试管的血液样本。结果:RT储存在K3EDTA管中的血液随时间显示pDNA和gDNA浓度增加。但是,在BCT中,pDNA和gDNA的水平至少保持稳定7天。在第14天,BCT中的pDNA增加了4.5倍,而K3EDTA管中增加了200倍以上。同样,在BCT中,gDNA在第14天增加了<2倍,而K3EDTA管中增加了456倍。样品运输后观察到相似的结果。结论:无细胞DNA BCT可以防止在样品存储和运输过程中由于有核细胞破裂而引起的gDNA污染。这种新颖的采血管提供了一种方法,用于获取稳定的cfDNA样品,以进行稀有靶标检测和准确分析,同时减轻gDNA污染的威胁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号